ALZN

Alzamend NeuroF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

RSI (14)

50.8

Neutral

MACD Hist

0.02

Bullish

ATR (14)

0.08

Normal

Vol Z (20)

-0.28

Normal

RET 20D

+6.5%

Positive

Dist 52W High

-71.3%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-02

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Downtrend (SMA20 < SMA50 < SMA200)

Momentum

Short-term rebound vs weak 3M trend · 20D +6.5% · 60D -45.7%

RSI / MACD

RSI 50.8 (Neutral) · MACD hist +0.02

Volatility

Volatility normal (Z -0.28)

SMA20

1.10

SMA50

1.12

SMA200

1.95

EMA12

1.13

EMA26

1.13

BB Upper

1.22

BB Mid

1.10

BB Lower

0.97

RET 5D

-0.9%

RET 20D

+6.5%

RET 60D

-45.7%

RET 120D

-47.5%

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology